Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SVRA Savara, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $5.15 -0.2% | $15.65 -4.0% |
| StockIQ Score | 40D Weak Risk: Medium | 41D Weak Risk: High |
| Technical | 19F | 36F |
| Fundamental | 50C- | 35F |
| Growth | 32F | 50C- |
| Fair Value | 38F | 38F |
| News | 74B | 50C- |
| Quality | 55C | 50C- |
| Risk | 46D+ | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Savara (SVRA) scores higher in fundamentals (50 vs. 35) and valuation (38 vs. 38), showing stronger financial health and pricing relative to its peers. Ascentage Pharma (AAPG) leads in growth (50 vs. 32), indicating faster expected expansion. Both carry a "WEAK" rating, but AAPG’s technical score (36 vs. 19) suggests slightly better short-term market momentum.
